Zepdon
Indicated to target viral replication in HIV management formulated to mitigate disease progression.
Strengths: 400mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Isentress
- Therapeutic class
Integrase Inhibitor
- Pharmacological class
Integrase Inhibitor
- Contraindications
hypersensitivity to raltegravir
- Precautions and warnings
monitor for muscle pain; report any signs of rash
- Minor side effects
headache; fatigue; nausea
- Moderate side effects
insomnia; abdominal pain
- Dosage forms
Tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Natco Pharma
- Onset Time
1–2 hours
- Duration
12 hours
- Storage instructions
Store at room temperature in a dry place.
- Drug interactions
Rifampicin; Antacids
- Age restrictions
Suitable for adolescents and adults.
Serious side effects
rhabdomyolysis — requires immediate medical attention; severe skin hypersensitivity reactions — requires immediate medical attention
Patient summary
Indicated to target viral replication in HIV management formulated to mitigate disease progression.
Mechanism of action
Raltegravir is an HIV-1 integrase strand transfer inhibitor that blocks the insertion of HIV DNA into the human genome, preventing the virus from replicating in host cells.
Pregnancy and breastfeeding
Pregnancy: Use recommended by specialist only. Breastfeeding: Advise against breastfeeding due to potential viral transmission.
Zepdon
Indicated to target viral replication in HIV management formulated to mitigate disease progression.
Editorial Notes
- Active ingredient(s): Raltegravir
- Listed indication(s): HIV Infection
Available option
- 60 tablets - 400 mg1453-400-mg-17496